Nonprostatic diseases on PSMA PET imaging: a spectrum of benign and malignant findings

• Published in: Cancer imaging Vol. 20; no. 1; p. 23
• Main Authors: de Galiza Barbosa, Felipe, Queiroz, Marcelo Araujo, Nunes, Rafael Fernandes, Costa, Larissa Bastos, Zaniboni, Elaine Caroline, Marin, José Flavio Gomes, Cerri, Giovanni Guido, Buchpiguel, Carlos Alberto
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 14.03.2020; BioMed Central; BMC
• Subjects: Antigens; Biochemistry; Cancer; CAT scans; Comparative analysis; Diagnosis; Diagnostic imaging; Diseases; Endothelium; Epidemiology; Etiology (Medicine); Ga-PSMA; Humans; Infections; Inflammation; Ligands; Medical research; Membrane Glycoproteins; Metastasis; Morphology; Neoplasms - diagnostic imaging; Organometallic Compounds; Positron emission; Positron emission tomography; Positron Emission Tomography Computed Tomography - methods; Positron Emission Tomography Computed Tomography - standards; Prostate cancer; Radiopharmaceuticals; Recurrence (Disease); Retirement benefits; Review; Sensitivity and Specificity; Tomography; Tumors; Positron emission tomography; Prostate cancer; Ga-PSMA

PSMA PET imaging was originally used to assess biochemical recurrence of prostate cancer (PCa), but its clinical use was promptly extended to detection, staging and therapy response assessment. The expanding use of PSMA PET worldwide has also revealed PSMA ligand uptake in diverse nonprostatic disea...